XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
X4 Pharmaceuticals, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.75+0.16 (+6.18%)
Close on Oct 19, 2026
- Market cap
- $347.45M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of X4 Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 7, 2026 | Oct 8, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 20, 2026 | Mar 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 17, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 22, 2025 | Aug 25, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2025 | Jun 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 25, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2025 | Apr 24, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 17, 2025 | Apr 18, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 25, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2025 | Feb 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 16, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 19, 2024 | Jul 19, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2024 | Jun 11, 2024 | SEC EDGAR |